Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Mosaic trisomy 9 is a chromosomal abnormality that can affect may parts of the body. In people affected by this condition, some of the body's cells have three copies of chromosome 9 (trisomy), while other cells have the usual two copies of this chromosome. The signs and symptoms vary but may include mild to severe intellectual disability, developmental delay, growth problems (both before and after birth), congenital heart defects, and/or abnormalities of the craniofacial (skull and face) region. Most cases are not inherited; it often occurs sporadically as a random event during the formation of the reproductive cells (egg and sperm) or as the fertilized egg divides. Treatment is based on the signs and symptoms present in each person.
Biomarker and diagnostic research for mosaic trisomy 9 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for mosaic trisomy 9.
16 publications have been identified in PubMed for mosaic trisomy 9. Research spans Case Report / Case Series (47%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 47% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 1:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
4 |
27% |
Disease patterns and progression | 2 | 13% |
Testing and diagnosis research | 1 | 7% |
Research summaries | 1 | 7% |
Harada Y (2026). [PMID: 41709511](https://pubmed.ncbi.nlm.nih.gov/41709511/). *Clin Exp Reprod Med*. [Epidemiology / Natural History]
Zagorac A (2026). [PMID: 42017141](https://pubmed.ncbi.nlm.nih.gov/42017141/). *Front Genet*. [Case Report / Case Series]
Ajour M (2026). [PMID: 41947226](https://pubmed.ncbi.nlm.nih.gov/41947226/). *J Med Case Rep*. [Case Report / Case Series]
Chen CP (2025). [PMID: 41213770](https://pubmed.ncbi.nlm.nih.gov/41213770/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]
Huang Y (2025). [PMID: 40799956](https://pubmed.ncbi.nlm.nih.gov/40799956/). *Pract Lab Med*. [Case Report / Case Series]
Chen CP (2025). [PMID: 41213768](https://pubmed.ncbi.nlm.nih.gov/41213768/). *Taiwan J Obstet Gynecol*. [Basic Science / Preclinical]
Chen CP (2025). [PMID: 41213769](https://pubmed.ncbi.nlm.nih.gov/41213769/). *Taiwan J Obstet Gynecol*. [Basic Science / Preclinical]
Iakovleva AS (2025). [PMID: 40995450](https://pubmed.ncbi.nlm.nih.gov/40995450/). *Vavilovskii Zhurnal Genet Selektsii*. [Case Report / Case Series]
Chen CP (2025). [PMID: 41213767](https://pubmed.ncbi.nlm.nih.gov/41213767/). *Taiwan J Obstet Gynecol*. [Basic Science / Preclinical]
Chen CP (2025). [PMID: 41213773](https://pubmed.ncbi.nlm.nih.gov/41213773/). *Taiwan J Obstet Gynecol*. [Basic Science / Preclinical]